Found 80 hits with Last Name = 'midha' and Initial = 'a' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50265896
(CHEMBL4070359)Show SMILES Cc1nn(-c2ccc(C)cn2)c2cc(ncc12)-c1ccc(cc1F)[C@H]1C[C@@H]1C(O)=O |r| Show InChI InChI=1S/C23H19FN4O2/c1-12-3-6-22(26-10-12)28-21-9-20(25-11-18(21)13(2)27-28)15-5-4-14(7-19(15)24)16-8-17(16)23(29)30/h3-7,9-11,16-17H,8H2,1-2H3,(H,29,30)/t16-,17+/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of Adenosine A2A receptor (unknown origin) |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50355462
(CHEMBL1835559)Show SMILES Cc1nc2ccccc2n1Cc1ccc(cn1)C(=O)N[C@@H]1CCC[C@@H]1C(=O)NO |r| Show InChI InChI=1S/C21H23N5O3/c1-13-23-18-6-2-3-8-19(18)26(13)12-15-10-9-14(11-22-15)20(27)24-17-7-4-5-16(17)21(28)25-29/h2-3,6,8-11,16-17,29H,4-5,7,12H2,1H3,(H,24,27)(H,25,28)/t16-,17+/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
Sun Pharma Advanced Research Company Ltd
Curated by ChEMBL
| Assay Description
Inhibition of TACE in human whole blood assessed as reduction of of LPS-induced TNFalpha production pretreated 15 mins before LPS challenge measured ... |
Eur J Med Chem 46: 5549-55 (2011)
Article DOI: 10.1016/j.ejmech.2011.09.018
BindingDB Entry DOI: 10.7270/Q2JQ11FF |
More data for this
Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50355463
(CHEMBL1835560)Show SMILES ONC(=O)[C@H]1CCC[C@H]1NC(=O)c1ccc(Cn2c(nc3ccccc23)C(F)(F)F)nc1 |r| Show InChI InChI=1S/C21H20F3N5O3/c22-21(23,24)20-27-16-5-1-2-7-17(16)29(20)11-13-9-8-12(10-25-13)18(30)26-15-6-3-4-14(15)19(31)28-32/h1-2,5,7-10,14-15,32H,3-4,6,11H2,(H,26,30)(H,28,31)/t14-,15+/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 74 | n/a | n/a | n/a | n/a | n/a | n/a |
Sun Pharma Advanced Research Company Ltd
Curated by ChEMBL
| Assay Description
Inhibition of TACE in human whole blood assessed as reduction of of LPS-induced TNFalpha production pretreated 15 mins before LPS challenge measured ... |
Eur J Med Chem 46: 5549-55 (2011)
Article DOI: 10.1016/j.ejmech.2011.09.018
BindingDB Entry DOI: 10.7270/Q2JQ11FF |
More data for this
Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50355458
(CHEMBL1835555)Show SMILES Cc1nc2ccccc2n1Cc1ccc(cn1)C(=O)N[C@@H]1CCOC[C@@H]1C(=O)NO |r| Show InChI InChI=1S/C21H23N5O4/c1-13-23-18-4-2-3-5-19(18)26(13)11-15-7-6-14(10-22-15)20(27)24-17-8-9-30-12-16(17)21(28)25-29/h2-7,10,16-17,29H,8-9,11-12H2,1H3,(H,24,27)(H,25,28)/t16-,17+/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | n/a |
Sun Pharma Advanced Research Company Ltd
Curated by ChEMBL
| Assay Description
Inhibition of TACE in human whole blood assessed as reduction of of LPS-induced TNFalpha production pretreated 15 mins before LPS challenge measured ... |
Eur J Med Chem 46: 5549-55 (2011)
Article DOI: 10.1016/j.ejmech.2011.09.018
BindingDB Entry DOI: 10.7270/Q2JQ11FF |
More data for this
Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50355460
(CHEMBL1835557)Show SMILES Cc1nc2ccccc2n1Cc1ccc(cn1)C(=O)N[C@@H]1CCCC[C@@H]1C(=O)NO |r| Show InChI InChI=1S/C22H25N5O3/c1-14-24-19-8-4-5-9-20(19)27(14)13-16-11-10-15(12-23-16)21(28)25-18-7-3-2-6-17(18)22(29)26-30/h4-5,8-12,17-18,30H,2-3,6-7,13H2,1H3,(H,25,28)(H,26,29)/t17-,18+/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 126 | n/a | n/a | n/a | n/a | n/a | n/a |
Sun Pharma Advanced Research Company Ltd
Curated by ChEMBL
| Assay Description
Inhibition of TACE in human whole blood assessed as reduction of of LPS-induced TNFalpha production pretreated 15 mins before LPS challenge measured ... |
Eur J Med Chem 46: 5549-55 (2011)
Article DOI: 10.1016/j.ejmech.2011.09.018
BindingDB Entry DOI: 10.7270/Q2JQ11FF |
More data for this
Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM26806
((3R,4R)-3-N-hydroxy-4-N-(4-{[2-(trifluoromethyl)-1...)Show SMILES ONC(=O)[C@H]1COCC[C@H]1NC(=O)c1ccc(Cn2c(nc3ccccc23)C(F)(F)F)cc1 |r| Show InChI InChI=1S/C22H21F3N4O4/c23-22(24,25)21-27-17-3-1-2-4-18(17)29(21)11-13-5-7-14(8-6-13)19(30)26-16-9-10-33-12-15(16)20(31)28-32/h1-8,15-16,32H,9-12H2,(H,26,30)(H,28,31)/t15-,16+/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Sun Pharma Advanced Research Company Ltd
Curated by ChEMBL
| Assay Description
Inhibition of TACE in human whole blood assessed as reduction of of LPS-induced TNFalpha production pretreated 15 mins before LPS challenge measured ... |
Eur J Med Chem 46: 5549-55 (2011)
Article DOI: 10.1016/j.ejmech.2011.09.018
BindingDB Entry DOI: 10.7270/Q2JQ11FF |
More data for this
Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50355459
(CHEMBL1835556)Show SMILES ONC(=O)[C@H]1COCC[C@H]1NC(=O)c1ccc(Cn2c(nc3ccccc23)C(F)(F)F)nc1 |r| Show InChI InChI=1S/C21H20F3N5O4/c22-21(23,24)20-27-16-3-1-2-4-17(16)29(20)10-13-6-5-12(9-25-13)18(30)26-15-7-8-33-11-14(15)19(31)28-32/h1-6,9,14-15,32H,7-8,10-11H2,(H,26,30)(H,28,31)/t14-,15+/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
Sun Pharma Advanced Research Company Ltd
Curated by ChEMBL
| Assay Description
Inhibition of TACE in human whole blood assessed as reduction of of LPS-induced TNFalpha production pretreated 15 mins before LPS challenge measured ... |
Eur J Med Chem 46: 5549-55 (2011)
Article DOI: 10.1016/j.ejmech.2011.09.018
BindingDB Entry DOI: 10.7270/Q2JQ11FF |
More data for this
Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50355461
(CHEMBL1835558)Show SMILES ONC(=O)[C@H]1CCCC[C@H]1NC(=O)c1ccc(Cn2c(nc3ccccc23)C(F)(F)F)nc1 |r| Show InChI InChI=1S/C22H22F3N5O3/c23-22(24,25)21-28-17-7-3-4-8-18(17)30(21)12-14-10-9-13(11-26-14)19(31)27-16-6-2-1-5-15(16)20(32)29-33/h3-4,7-11,15-16,33H,1-2,5-6,12H2,(H,27,31)(H,29,32)/t15-,16+/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 280 | n/a | n/a | n/a | n/a | n/a | n/a |
Sun Pharma Advanced Research Company Ltd
Curated by ChEMBL
| Assay Description
Inhibition of TACE in human whole blood assessed as reduction of of LPS-induced TNFalpha production pretreated 15 mins before LPS challenge measured ... |
Eur J Med Chem 46: 5549-55 (2011)
Article DOI: 10.1016/j.ejmech.2011.09.018
BindingDB Entry DOI: 10.7270/Q2JQ11FF |
More data for this
Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
(Homo sapiens (Human)) | BDBM50265895
(CHEMBL4097537)Show SMILES COc1nn(-c2ccccn2)c2cc(ccc12)-c1ccc(cc1)[C@H]1C[C@@H]1C(O)=O |r| Show InChI InChI=1S/C23H19N3O3/c1-29-22-17-10-9-16(12-20(17)26(25-22)21-4-2-3-11-24-21)14-5-7-15(8-6-14)18-13-19(18)23(27)28/h2-12,18-19H,13H2,1H3,(H,27,28)/t18-,19+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of phosphodiesterase 4D (unknown origin) |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265860
(CHEMBL4082804)Show SMILES Cc1nn(-c2ccccn2)c2cc(ccc12)-c1ccc(CC(O)=O)cc1 Show InChI InChI=1S/C21H17N3O2/c1-14-18-10-9-17(16-7-5-15(6-8-16)12-21(25)26)13-19(18)24(23-14)20-4-2-3-11-22-20/h2-11,13H,12H2,1H3,(H,25,26) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.70E+4 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265862
(CHEMBL4077507)Show SMILES Cc1nn(-c2ccccn2)c2cc(ccc12)-c1ccc(CCC(O)=O)cc1 Show InChI InChI=1S/C22H19N3O2/c1-15-19-11-10-18(17-8-5-16(6-9-17)7-12-22(26)27)14-20(19)25(24-15)21-4-2-3-13-23-21/h2-6,8-11,13-14H,7,12H2,1H3,(H,26,27) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 640 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265865
(CHEMBL4076190)Show SMILES Cc1nn(-c2ccccn2)c2cc(ccc12)-c1ccc(CCCC(O)=O)cc1 Show InChI InChI=1S/C23H21N3O2/c1-16-20-13-12-19(15-21(20)26(25-16)22-6-2-3-14-24-22)18-10-8-17(9-11-18)5-4-7-23(27)28/h2-3,6,8-15H,4-5,7H2,1H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 260 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265868
(CHEMBL4071228)Show SMILES Cc1nn(-c2ccccn2)c2cc(ccc12)-c1cccc(CCC(O)=O)c1 Show InChI InChI=1S/C22H19N3O2/c1-15-19-10-9-18(17-6-4-5-16(13-17)8-11-22(26)27)14-20(19)25(24-15)21-7-2-3-12-23-21/h2-7,9-10,12-14H,8,11H2,1H3,(H,26,27) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.70E+4 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265874
(CHEMBL4085695)Show SMILES Cc1nn(-c2ccccn2)c2cc(ncc12)-c1ccc(CCC(O)=O)cc1 Show InChI InChI=1S/C21H18N4O2/c1-14-17-13-23-18(16-8-5-15(6-9-16)7-10-21(26)27)12-19(17)25(24-14)20-4-2-3-11-22-20/h2-6,8-9,11-13H,7,10H2,1H3,(H,26,27) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 2.60E+3 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265875
(CHEMBL4070273)Show SMILES COc1cc(CCC(O)=O)ccc1-c1ccc2c(C)nn(-c3ccccn3)c2c1 Show InChI InChI=1S/C23H21N3O3/c1-15-18-10-8-17(14-20(18)26(25-15)22-5-3-4-12-24-22)19-9-6-16(7-11-23(27)28)13-21(19)29-2/h3-6,8-10,12-14H,7,11H2,1-2H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 720 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265876
(CHEMBL4077353)Show SMILES Cc1nn(-c2ccccn2)c2cc(ccc12)-c1ccc(CCC(O)=O)cc1C#N Show InChI InChI=1S/C23H18N4O2/c1-15-19-9-7-17(13-21(19)27(26-15)22-4-2-3-11-25-22)20-8-5-16(6-10-23(28)29)12-18(20)14-24/h2-5,7-9,11-13H,6,10H2,1H3,(H,28,29) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 2.40E+3 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265877
(CHEMBL4101071)Show SMILES Cc1nn(-c2ccccn2)c2cc(ccc12)-c1ccc(CCC(O)=O)cc1Cl Show InChI InChI=1S/C22H18ClN3O2/c1-14-17-9-7-16(13-20(17)26(25-14)21-4-2-3-11-24-21)18-8-5-15(12-19(18)23)6-10-22(27)28/h2-5,7-9,11-13H,6,10H2,1H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 710 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265878
(CHEMBL4060517)Show SMILES OC(=O)CCc1ccc(cc1)-c1ccc2cnn(-c3ccccn3)c2c1 Show InChI InChI=1S/C21H17N3O2/c25-21(26)11-6-15-4-7-16(8-5-15)17-9-10-18-14-23-24(19(18)13-17)20-3-1-2-12-22-20/h1-5,7-10,12-14H,6,11H2,(H,25,26) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 990 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265879
(CHEMBL4065429)Show SMILES OC(=O)CCc1ccc(cc1)-c1ccc2c(OCc3ccccc3)nn(-c3ccccn3)c2c1 Show InChI InChI=1S/C28H23N3O3/c32-27(33)16-11-20-9-12-22(13-10-20)23-14-15-24-25(18-23)31(26-8-4-5-17-29-26)30-28(24)34-19-21-6-2-1-3-7-21/h1-10,12-15,17-18H,11,16,19H2,(H,32,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.70E+4 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265880
(CHEMBL4076004)Show SMILES CCc1nn(-c2ccccn2)c2cc(ccc12)-c1ccc(CCC(O)=O)cc1 Show InChI InChI=1S/C23H21N3O2/c1-2-20-19-12-11-18(17-9-6-16(7-10-17)8-13-23(27)28)15-21(19)26(25-20)22-5-3-4-14-24-22/h3-7,9-12,14-15H,2,8,13H2,1H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 760 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265881
(CHEMBL4065890)Show SMILES OC(=O)CCc1ccc(cc1)-c1ccc2c(nn(-c3ccccn3)c2c1)C#N Show InChI InChI=1S/C22H16N4O2/c23-14-19-18-10-9-17(16-7-4-15(5-8-16)6-11-22(27)28)13-20(18)26(25-19)21-3-1-2-12-24-21/h1-5,7-10,12-13H,6,11H2,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 4.80E+3 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265882
(CHEMBL4089919)Show SMILES OC(=O)CCc1ccc(cc1)-c1cc(F)c2cnn(-c3ccccn3)c2c1 Show InChI InChI=1S/C21H16FN3O2/c22-18-11-16(15-7-4-14(5-8-15)6-9-21(26)27)12-19-17(18)13-24-25(19)20-3-1-2-10-23-20/h1-5,7-8,10-13H,6,9H2,(H,26,27) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 470 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265883
(CHEMBL4068825)Show SMILES OC(=O)CCc1ccc(cc1)-c1cc(C#N)c2cnn(-c3ccccn3)c2c1 Show InChI InChI=1S/C22H16N4O2/c23-13-18-11-17(16-7-4-15(5-8-16)6-9-22(27)28)12-20-19(18)14-25-26(20)21-3-1-2-10-24-21/h1-5,7-8,10-12,14H,6,9H2,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265889
(CHEMBL4097652)Show SMILES C[C@@H](Cc1ccc(cc1)-c1ccc2cnn(-c3ccccn3)c2c1)C(O)=O |r| Show InChI InChI=1S/C22H19N3O2/c1-15(22(26)27)12-16-5-7-17(8-6-16)18-9-10-19-14-24-25(20(19)13-18)21-4-2-3-11-23-21/h2-11,13-15H,12H2,1H3,(H,26,27)/t15-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 4.00E+3 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265890
(CHEMBL4071523)Show SMILES CC(CC(O)=O)c1ccc(cc1)-c1cc2n(nc(C)c2cn1)-c1ccccn1 Show InChI InChI=1S/C22H20N4O2/c1-14(11-22(27)28)16-6-8-17(9-7-16)19-12-20-18(13-24-19)15(2)25-26(20)21-5-3-4-10-23-21/h3-10,12-14H,11H2,1-2H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.20E+4 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265891
(CHEMBL4060171)Show SMILES Cc1nn(-c2ccccn2)c2cc(ccc12)-c1ccc(cc1)[C@H]1C[C@@H]1C(O)=O |r| Show InChI InChI=1S/C23H19N3O2/c1-14-18-10-9-17(12-21(18)26(25-14)22-4-2-3-11-24-22)15-5-7-16(8-6-15)19-13-20(19)23(27)28/h2-12,19-20H,13H2,1H3,(H,27,28)/t19-,20+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 850 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265891
(CHEMBL4060171)Show SMILES Cc1nn(-c2ccccn2)c2cc(ccc12)-c1ccc(cc1)[C@H]1C[C@@H]1C(O)=O |r| Show InChI InChI=1S/C23H19N3O2/c1-14-18-10-9-17(12-21(18)26(25-14)22-4-2-3-11-24-22)15-5-7-16(8-6-15)19-13-20(19)23(27)28/h2-12,19-20H,13H2,1H3,(H,27,28)/t19-,20+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 850 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265892
(CHEMBL4078672)Show SMILES Cc1nn(-c2ccccn2)c2cc(ccc12)-c1ccc(cc1)[C@@H]1C[C@H]1C(O)=O |r| Show InChI InChI=1S/C23H19N3O2/c1-14-18-10-9-17(12-21(18)26(25-14)22-4-2-3-11-24-22)15-5-7-16(8-6-15)19-13-20(19)23(27)28/h2-12,19-20H,13H2,1H3,(H,27,28)/t19-,20+/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.70E+4 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265893
(CHEMBL4102951)Show SMILES Cc1nn(-c2ccc(C)cc2)c2cc(ncc12)-c1ccc(cc1)[C@H]1C[C@@H]1C(O)=O |r| Show InChI InChI=1S/C24H21N3O2/c1-14-3-9-18(10-4-14)27-23-12-22(25-13-21(23)15(2)26-27)17-7-5-16(6-8-17)19-11-20(19)24(28)29/h3-10,12-13,19-20H,11H2,1-2H3,(H,28,29)/t19-,20+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 900 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265894
(CHEMBL4080998)Show SMILES COc1nn(-c2ccccn2)c2cc(cc(F)c12)-c1ccc(cc1)[C@H]1C[C@@H]1C(O)=O |r| Show InChI InChI=1S/C23H18FN3O3/c1-30-22-21-18(24)10-15(11-19(21)27(26-22)20-4-2-3-9-25-20)13-5-7-14(8-6-13)16-12-17(16)23(28)29/h2-11,16-17H,12H2,1H3,(H,28,29)/t16-,17+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 510 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265895
(CHEMBL4097537)Show SMILES COc1nn(-c2ccccn2)c2cc(ccc12)-c1ccc(cc1)[C@H]1C[C@@H]1C(O)=O |r| Show InChI InChI=1S/C23H19N3O3/c1-29-22-17-10-9-16(12-20(17)26(25-22)21-4-2-3-11-24-21)14-5-7-15(8-6-14)18-13-19(18)23(27)28/h2-12,18-19H,13H2,1H3,(H,27,28)/t18-,19+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 470 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265896
(CHEMBL4070359)Show SMILES Cc1nn(-c2ccc(C)cn2)c2cc(ncc12)-c1ccc(cc1F)[C@H]1C[C@@H]1C(O)=O |r| Show InChI InChI=1S/C23H19FN4O2/c1-12-3-6-22(26-10-12)28-21-9-20(25-11-18(21)13(2)27-28)15-5-4-14(7-19(15)24)16-8-17(16)23(29)30/h3-7,9-11,16-17H,8H2,1-2H3,(H,29,30)/t16-,17+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 740 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Homo sapiens (Human)) | BDBM50265897
(CHEMBL4096579)Show SMILES COc1nn(-c2ccc(C)cc2)c2cc(cc(F)c12)-c1ccc(cc1)[C@H]1C[C@@H]1C(O)=O |r| Show InChI InChI=1S/C25H21FN2O3/c1-14-3-9-18(10-4-14)28-22-12-17(11-21(26)23(22)24(27-28)31-2)15-5-7-16(8-6-15)19-13-20(19)25(29)30/h3-12,19-20H,13H2,1-2H3,(H,29,30)/t19-,20+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 78 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 1
(Mus musculus) | BDBM50265862
(CHEMBL4077507)Show SMILES Cc1nn(-c2ccccn2)c2cc(ccc12)-c1ccc(CCC(O)=O)cc1 Show InChI InChI=1S/C22H19N3O2/c1-15-19-11-10-18(17-8-5-16(6-9-17)7-12-22(26)27)14-20(19)25(24-15)21-4-2-3-13-23-21/h2-6,8-11,13-14H,7,12H2,1H3,(H,26,27) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at mouse GPR40 expressed in HEK293 cells assessed as increase in intracellular calcium level after 5 mins by FLUO-4-AM dye-based FLI... |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 1
(Mus musculus) | BDBM50265865
(CHEMBL4076190)Show SMILES Cc1nn(-c2ccccn2)c2cc(ccc12)-c1ccc(CCCC(O)=O)cc1 Show InChI InChI=1S/C23H21N3O2/c1-16-20-13-12-19(15-21(20)26(25-16)22-6-2-3-14-24-22)18-10-8-17(9-11-18)5-4-7-23(27)28/h2-3,6,8-15H,4-5,7H2,1H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 2.10E+3 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at mouse GPR40 expressed in HEK293 cells assessed as increase in intracellular calcium level after 5 mins by FLUO-4-AM dye-based FLI... |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 1
(Mus musculus) | BDBM50265868
(CHEMBL4071228)Show SMILES Cc1nn(-c2ccccn2)c2cc(ccc12)-c1cccc(CCC(O)=O)c1 Show InChI InChI=1S/C22H19N3O2/c1-15-19-10-9-18(17-6-4-5-16(13-17)8-11-22(26)27)14-20(19)25(24-15)21-7-2-3-12-23-21/h2-7,9-10,12-14H,8,11H2,1H3,(H,26,27) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at mouse GPR40 expressed in HEK293 cells assessed as increase in intracellular calcium level after 5 mins by FLUO-4-AM dye-based FLI... |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 1
(Mus musculus) | BDBM50265875
(CHEMBL4070273)Show SMILES COc1cc(CCC(O)=O)ccc1-c1ccc2c(C)nn(-c3ccccn3)c2c1 Show InChI InChI=1S/C23H21N3O3/c1-15-18-10-8-17(14-20(18)26(25-15)22-5-3-4-12-24-22)19-9-6-16(7-11-23(27)28)13-21(19)29-2/h3-6,8-10,12-14H,7,11H2,1-2H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 8.20E+3 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at mouse GPR40 expressed in HEK293 cells assessed as increase in intracellular calcium level after 5 mins by FLUO-4-AM dye-based FLI... |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 1
(Mus musculus) | BDBM50265876
(CHEMBL4077353)Show SMILES Cc1nn(-c2ccccn2)c2cc(ccc12)-c1ccc(CCC(O)=O)cc1C#N Show InChI InChI=1S/C23H18N4O2/c1-15-19-9-7-17(13-21(19)27(26-15)22-4-2-3-11-25-22)20-8-5-16(6-10-23(28)29)12-18(20)14-24/h2-5,7-9,11-13H,6,10H2,1H3,(H,28,29) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 6.10E+3 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at mouse GPR40 expressed in HEK293 cells assessed as increase in intracellular calcium level after 5 mins by FLUO-4-AM dye-based FLI... |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 1
(Mus musculus) | BDBM50265898
(CHEMBL4075162)Show SMILES Cc1nn(-c2ccccn2)c2cc(ccc12)-c1ccc(CCC(O)=O)cc1F Show InChI InChI=1S/C22H18FN3O2/c1-14-17-9-7-16(13-20(17)26(25-14)21-4-2-3-11-24-21)18-8-5-15(12-19(18)23)6-10-22(27)28/h2-5,7-9,11-13H,6,10H2,1H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at mouse GPR40 expressed in HEK293 cells assessed as increase in intracellular calcium level after 5 mins by FLUO-4-AM dye-based FLI... |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 1
(Mus musculus) | BDBM50265878
(CHEMBL4060517)Show SMILES OC(=O)CCc1ccc(cc1)-c1ccc2cnn(-c3ccccn3)c2c1 Show InChI InChI=1S/C21H17N3O2/c25-21(26)11-6-15-4-7-16(8-5-15)17-9-10-18-14-23-24(19(18)13-17)20-3-1-2-12-22-20/h1-5,7-10,12-14H,6,11H2,(H,25,26) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 4.50E+3 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at mouse GPR40 expressed in HEK293 cells assessed as increase in intracellular calcium level after 5 mins by FLUO-4-AM dye-based FLI... |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 1
(Mus musculus) | BDBM50265899
(CHEMBL4087992)Show SMILES COc1nn(-c2ccccn2)c2cc(ccc12)-c1ccc(CCC(O)=O)cc1 Show InChI InChI=1S/C22H19N3O3/c1-28-22-18-11-10-17(16-8-5-15(6-9-16)7-12-21(26)27)14-19(18)25(24-22)20-4-2-3-13-23-20/h2-6,8-11,13-14H,7,12H2,1H3,(H,26,27) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | 2.60E+3 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at mouse GPR40 expressed in HEK293 cells assessed as increase in intracellular calcium level after 5 mins by FLUO-4-AM dye-based FLI... |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 1
(Mus musculus) | BDBM50265879
(CHEMBL4065429)Show SMILES OC(=O)CCc1ccc(cc1)-c1ccc2c(OCc3ccccc3)nn(-c3ccccn3)c2c1 Show InChI InChI=1S/C28H23N3O3/c32-27(33)16-11-20-9-12-22(13-10-20)23-14-15-24-25(18-23)31(26-8-4-5-17-29-26)30-28(24)34-19-21-6-2-1-3-7-21/h1-10,12-15,17-18H,11,16,19H2,(H,32,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at mouse GPR40 expressed in HEK293 cells assessed as increase in intracellular calcium level after 5 mins by FLUO-4-AM dye-based FLI... |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 1
(Mus musculus) | BDBM50265881
(CHEMBL4065890)Show SMILES OC(=O)CCc1ccc(cc1)-c1ccc2c(nn(-c3ccccn3)c2c1)C#N Show InChI InChI=1S/C22H16N4O2/c23-14-19-18-10-9-17(16-7-4-15(5-8-16)6-11-22(27)28)13-20(18)26(25-19)21-3-1-2-12-24-21/h1-5,7-10,12-13H,6,11H2,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at mouse GPR40 expressed in HEK293 cells assessed as increase in intracellular calcium level after 5 mins by FLUO-4-AM dye-based FLI... |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 1
(Mus musculus) | BDBM50265903
(CHEMBL4087308)Show SMILES Cc1cc(cc2n(ncc12)-c1ccccn1)-c1ccc(CCC(O)=O)cc1 Show InChI InChI=1S/C22H19N3O2/c1-15-12-18(17-8-5-16(6-9-17)7-10-22(26)27)13-20-19(15)14-24-25(20)21-4-2-3-11-23-21/h2-6,8-9,11-14H,7,10H2,1H3,(H,26,27) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 2.60E+3 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at mouse GPR40 expressed in HEK293 cells assessed as increase in intracellular calcium level after 5 mins by FLUO-4-AM dye-based FLI... |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Mus musculus) | BDBM50265893
(CHEMBL4102951)Show SMILES Cc1nn(-c2ccc(C)cc2)c2cc(ncc12)-c1ccc(cc1)[C@H]1C[C@@H]1C(O)=O |r| Show InChI InChI=1S/C24H21N3O2/c1-14-3-9-18(10-4-14)27-23-12-22(25-13-21(23)15(2)26-27)17-7-5-16(6-8-17)19-11-20(19)24(28)29/h3-10,12-13,19-20H,11H2,1-2H3,(H,28,29)/t19-,20+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 640 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at mouse GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Mus musculus) | BDBM50265894
(CHEMBL4080998)Show SMILES COc1nn(-c2ccccn2)c2cc(cc(F)c12)-c1ccc(cc1)[C@H]1C[C@@H]1C(O)=O |r| Show InChI InChI=1S/C23H18FN3O3/c1-30-22-21-18(24)10-15(11-19(21)27(26-22)20-4-2-3-9-25-20)13-5-7-14(8-6-13)16-12-17(16)23(28)29/h2-11,16-17H,12H2,1H3,(H,28,29)/t16-,17+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 620 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at mouse GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Mus musculus) | BDBM50265895
(CHEMBL4097537)Show SMILES COc1nn(-c2ccccn2)c2cc(ccc12)-c1ccc(cc1)[C@H]1C[C@@H]1C(O)=O |r| Show InChI InChI=1S/C23H19N3O3/c1-29-22-17-10-9-16(12-20(17)26(25-22)21-4-2-3-11-24-21)14-5-7-15(8-6-14)18-13-19(18)23(27)28/h2-12,18-19H,13H2,1H3,(H,27,28)/t18-,19+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 410 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at mouse GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Mus musculus) | BDBM50265896
(CHEMBL4070359)Show SMILES Cc1nn(-c2ccc(C)cn2)c2cc(ncc12)-c1ccc(cc1F)[C@H]1C[C@@H]1C(O)=O |r| Show InChI InChI=1S/C23H19FN4O2/c1-12-3-6-22(26-10-12)28-21-9-20(25-11-18(21)13(2)27-28)15-5-4-14(7-19(15)24)16-8-17(16)23(29)30/h3-7,9-11,16-17H,8H2,1-2H3,(H,29,30)/t16-,17+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at mouse GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 4
(Mus musculus) | BDBM50265897
(CHEMBL4096579)Show SMILES COc1nn(-c2ccc(C)cc2)c2cc(cc(F)c12)-c1ccc(cc1)[C@H]1C[C@@H]1C(O)=O |r| Show InChI InChI=1S/C25H21FN2O3/c1-14-3-9-18(10-4-14)28-22-12-17(11-21(26)23(22)24(27-28)31-2)15-5-7-16(8-6-15)19-13-20(19)25(29)30/h3-12,19-20H,13H2,1-2H3,(H,29,30)/t19-,20+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 17 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at mouse GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Free fatty acid receptor 1
(Mus musculus) | BDBM50265882
(CHEMBL4089919)Show SMILES OC(=O)CCc1ccc(cc1)-c1cc(F)c2cnn(-c3ccccn3)c2c1 Show InChI InChI=1S/C21H16FN3O2/c22-18-11-16(15-7-4-14(5-8-15)6-9-21(26)27)12-19-17(18)13-24-25(19)20-3-1-2-10-23-20/h1-5,7-8,10-13H,6,9H2,(H,26,27) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 2.60E+3 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Agonist activity at mouse GPR40 expressed in HEK293 cells assessed as increase in intracellular calcium level after 5 mins by FLUO-4-AM dye-based FLI... |
J Med Chem 60: 3187-3197 (2017)
Article DOI: 10.1021/acs.jmedchem.7b00210
BindingDB Entry DOI: 10.7270/Q2PZ5C9Z |
More data for this
Ligand-Target Pair | |
Search and Browse
